2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Theca Cell Tumor in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yuan, ZQ | 1 |
| Sun, M | 1 |
| Feldman, RI | 1 |
| Wang, G | 1 |
| Ma, X | 1 |
| Jiang, C | 1 |
| Coppola, D | 1 |
| Nicosia, SV | 1 |
| Cheng, JQ | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Theca Cell Tumor
| Article | Year |
|---|---|
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adenosarcoma; Amino Acid Sequence; Apoptosis; B | 2000 |